Medicinal Mushrooms: Lion's Mane, Reishi, Cordyceps, and the Science of Beta-Glucans

The cell walls of fungi are built from chitin and beta-glucans, long glucose polymers that the human immune system reads as a danger signal. Eat a medicinal mushroom and you are ingesting compounds that quietly train innate immunity, modulate inflammation, and in some cases influence nerve growth in the brain. Memorial Sloan Kettering's About Herbs database maintains detailed reference pages on the most studied species, and the NIH National Center for Complementary and Integrative Health (NCCIH) tracks clinical evidence. The picture that emerges is more nuanced than the wellness marketing suggests. A few species have real human trial data, most do not, and the differences between fruiting body, mycelium, and extract matter enormously.

What "medicinal mushroom" actually means

The phrase covers two overlapping categories. Culinary medicinal mushrooms (shiitake, maitake, oyster, porcini) are eaten as food and have documented bioactive compounds. Functional or traditional medicinal mushrooms (reishi, lion's mane, cordyceps, turkey tail, chaga) are typically consumed as powders, extracts, or teas because their texture is woody or unpalatable. Both categories contain beta-glucans, terpenes, and other compounds of interest, but the traditional medicinal species have longer histories in Chinese, Japanese, and Siberian medicine and a growing body of modern research.

Three parts of the fungus appear in supplements, and they are not interchangeable:

• Fruiting body is the mushroom you see above ground. It is the traditional form used in herbal medicine and the source of most beta-glucans and terpenes.
• Mycelium is the root-like network grown on grain or liquid substrate. It contains some bioactives but is often mostly starch from the growth medium unless carefully extracted.
• Extracts concentrate specific compounds. Hot water extraction pulls beta-glucans. Alcohol extraction pulls terpenes. Dual extraction does both.

A cheap "mushroom blend" supplement listing mycelium on grain as the first ingredient is mostly starch. Look for products that specify fruiting body, list beta-glucan content (typically 20 to 40 percent by weight for a good extract), and disclose extraction method. The NIH Office of Dietary Supplements notes that supplement quality is the single largest source of inconsistency in mushroom research.

Beta-glucans: the compound that does most of the work

Beta-glucans are linear or branched polymers of D-glucose linked by beta-glycosidic bonds. The (1,3)(1,6)-beta-glucans found in fungi are structurally distinct from the (1,3)(1,4)-beta-glucans in oats and barley, and they have very different biological effects. Fungal beta-glucans bind to receptors on macrophages, neutrophils, and natural killer cells (notably Dectin-1, CR3, and TLR-2/6), priming the innate immune system without causing inflammation on their own.

The downstream effects documented in animal and human studies include enhanced natural killer cell activity, increased cytokine production in response to pathogens, and improved clearance of bacterial and viral challenges. A 2019 systematic review in Advances in Therapy pooled 13 human trials of yeast-derived beta-glucans and reported reduced severity and duration of upper respiratory tract infections, with effect sizes comparable to those of vitamin C or zinc. The Memorial Sloan Kettering About Herbs database notes that beta-glucan supplementation is generally well tolerated but that high-quality human data for specific mushroom species remains limited.

Lion's mane (Hericium erinaceus): cognition and nerve growth

Lion's mane is the most interesting medicinal mushroom from a neuroscience perspective. It produces two classes of compounds, hericenones (from the fruiting body) and erinacines (from the mycelium), that cross the blood-brain barrier and stimulate nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) synthesis in animal models. NGF and BDNF are proteins essential for the growth, maintenance, and survival of neurons, and their decline is implicated in age-related cognitive impairment.

Human data is limited but suggestive. A 2009 double-blind trial in Japan randomized 30 older adults with mild cognitive impairment to 3 g per day of lion's mane powder versus placebo for 16 weeks. The treatment group showed improved cognitive scores on the Revised Hasegawa Dementia Scale, with the benefit fading four weeks after supplementation stopped, suggesting the effect was dependent on continued intake. A 2020 trial in Frontiers in Aging Neuroscience gave 1.8 g of standardized lion's mane extract to 41 adults aged 50 to 80 for 16 weeks and found modest improvements in verbal memory and subjective mood. The effect sizes were small, the samples were modest, and the trials have not been replicated at scale. Lion's mane looks promising for age-related cognitive support, but it is not a proven treatment for dementia or Alzheimer's.

Reishi (Ganoderma lucidum): stress, sleep, and immunity

Reishi, called lingzhi in Chinese, is the "mushroom of immortality" of traditional East Asian medicine. It is one of the most bitter substances in the fungal kingdom, owing to its high triterpene content, and is essentially inedible as a food. Its triterpenes (ganoderic acids) and beta-glucans have been studied for stress, sleep, immune modulation, and inflammation.

A 2012 trial in Pharmacology, Biochemistry, and Behavior gave 1.8 g of reishi extract or placebo to 132 people with neurasthenia (a syndrome of fatigue, irritability, and headache) for 8 weeks. The treatment group reported reduced fatigue and improved well-being. A small 2021 trial in International Journal of Molecular Sciences found that 4 weeks of reishi supplementation reduced self-reported anxiety and improved sleep quality in breast cancer survivors. The immune data is more consistent in animal models than in humans, but a 2017 systematic review in Cochrane Database of Systematic Reviews concluded that the human evidence for reishi as a cancer adjunct was insufficient to recommend its use, while noting that adverse events were uncommon. Memorial Sloan Kettering flags reishi as potentially interacting with anticoagulants and antihypertensives, and as possibly additive with immunosuppressive drugs.

Cordyceps: endurance and ATP

Cordyceps is a genus of fungi that parasitize insects in the wild, growing out of the host's body. The two species used in supplements are Cordyceps sinensis (the wild Tibetan fungus, which can cost thousands of dollars per kilogram) and Cordyceps militaris (cultivated, more affordable, and often higher in the active compound cordycepin). The compound of greatest interest is cordycepin, an adenosine analog with anti-inflammatory and purported endurance-enhancing effects.

The human trials on cordyceps for exercise performance are mixed. A 2010 study in Journal of Alternative and Complementary Medicine gave older adults 3 g per day of C. sinensis for 12 weeks and found modest improvements in metabolic threshold and exercise tolerance. A 2016 trial in the same journal using a Cordyceps militaris extract (CS-4) at 2.4 g per day for 12 weeks found no meaningful improvement in VO2 max or endurance in trained cyclists. A 2020 double-blind trial using a higher-dose C. militaris extract reported improved treadmill time to exhaustion, but the effect was small (about 5 percent) and only in sedentary adults. The evidence does not support cordyceps as a performance-enhancing supplement for trained athletes, but it may offer modest benefits for older or sedentary adults. The NCCIH notes that most cordyceps studies have methodological limitations.

Turkey tail, shiitake, and maitake

Turkey tail (Trametes versicolor) contains the beta-glucan PSK (polysaccharide-K, also called krestin), which has been used as an adjuvant cancer therapy in Japan for decades. A 2022 meta-analysis in Medicine pooled 26 trials of PSK in gastric cancer and found improved five-year survival when added to chemotherapy. The evidence is strongest for gastric and colorectal cancers in Asian populations, and PSK is approved as a prescription drug in Japan, not as a supplement in the West. Shiitake contains lentinan, a beta-glucan studied in similar adjuvant contexts, and eritadenine, a compound that lowers cholesterol in animal models. Maitake contains the beta-glucan D-fraction, which has immune-modulating effects in cell and animal studies. None of these should be used as a substitute for medical cancer treatment, but the adjuvant data is real and worth discussing with an oncologist.

Dosing and product quality

The single biggest problem in mushroom supplementation is product quality. A 2017 study in Nature specifically about nootropic supplements found widespread adulteration and mislabeling, and a 2020 analysis in International Journal of Medicinal Mushrooms tested 19 mushroom supplements and found that 74 percent contained fillers, were not the species claimed, or contained negligible beta-glucans. To navigate this:

• Look for fruiting body, not mycelium on grain. The label should specify "fruiting body" or "fruit bodies."
• Look for beta-glucan content on the label or certificate of analysis. A good extract lists 20 to 40 percent beta-glucans by weight.
• Look for extraction method. Hot water extracts beta-glucans, alcohol extracts terpenes, dual extracts both. Reishi and lion's mane benefit from dual extraction.
• Look for third-party testing from NSF, USP, or ConsumerLab. The supplement industry is poorly regulated.
• Be skeptical of "8-mushroom blend" products. They typically contain tiny amounts of each species, mostly rice flour, and rarely any disclosure of bioactives.

Dosing in clinical trials has typically been 1 to 3 g per day of fruiting body extract, often split into two or three doses. The effects accumulate over weeks to months, not days. Stop any mushroom supplement two weeks before surgery because of theoretical bleeding and immune interaction risks flagged by Memorial Sloan Kettering.

Safety and drug interactions

Medicinal mushrooms are generally well tolerated at typical doses. The most common side effects are mild gastrointestinal upset and, with reishi, dry mouth or throat. More serious concerns are drug-specific:

• Reishi may have anticoagulant and antihypertensive effects. Avoid combining with blood thinners (warfarin, aspirin, clopidogrel) or antihypertensives without medical supervision.
• Immune-modulating mushrooms (reishi, turkey tail, maitake) may interfere with immunosuppressive drugs used in autoimmune disease or after organ transplant.
• Mushrooms grown on heavy-metal-contaminated substrate can accumulate lead, arsenic, and cadmium. Buy only from suppliers who test for heavy metals.
• Allergic reactions are possible, particularly in people with mold allergies.

The Memorial Sloan Kettering About Herbs database is the most accessible reference for clinicians, with species-specific interactions, dosing used in trials, and summaries of the human evidence. The NCCIH maintains consumer-facing fact sheets. Neither recommends mushrooms as a treatment for any disease, and neither has approved any mushroom product as a drug.

Practical recommendations

For most healthy adults, culinary mushrooms are the higher-confidence play. Add shiitake, maitake, oyster, or button mushrooms to your diet two or three times per week. A 2019 cohort study in Nutrients linked higher mushroom consumption to lower all-cause mortality, with the effect size modest but consistent across populations. The mechanism is likely a combination of beta-glucans, B vitamins, ergothioneine (an antioxidant amino acid), and substitution of mushrooms for less healthy foods.

For supplement use, the strongest evidence supports lion's mane for age-related cognitive support (1 to 3 g per day of fruiting body extract for at least 8 weeks) and reishi for stress and sleep (1 to 2 g per day of dual extract). Cordyceps has weaker evidence for endurance and is best viewed as experimental. Turkey tail, shiitake, and maitake extracts should be discussed with an oncologist if used as cancer adjuncts, not self-prescribed. Track any supplement changes against subjective markers like sleep, mood, and energy in the food diary, and avoid the temptation to stack five mushroom species at once.

Food first: culinary mushrooms as medicine

Before reaching for a supplement, consider that ordinary culinary mushrooms are a remarkably underrated food. A large 2019 cohort in Nutrients following over 15,000 Americans found that those who ate mushrooms at least twice per week had a 33 percent lower all-cause mortality risk over an average 19 years of follow-up, even after adjusting for age, sex, BMI, physical activity, smoking, and overall diet quality. The mechanism is probably multifactorial: beta-glucans, ergothioneine (a unique antioxidant amino acid that accumulates in tissues and may protect against oxidative damage), B vitamins, and the substitution effect of mushrooms displacing less nutritious foods from the plate.

Ergothioneine deserves special mention. It has a dedicated transporter (OCTN1) expressed in nearly every human tissue, concentrated in red blood cells, bone marrow, and seminal fluid. The body treats it as essential even though it has no officially recognized dietary reference intake. Mushroom intake is the dominant determinant of blood ergothioneine levels in humans. A 2020 review in Antioxidants proposed that ergothioneine may be a "longevity vitamin" whose chronic deficiency contributes to age-related disease. The hypothesis is unproven but plausible, and it provides additional rationale for treating mushrooms as a regular food rather than an occasional garnish.

Practical culinary advice: saute mushrooms in olive oil with garlic, add them to omelets, stir-fries, and grain bowls, or roast them with thyme and salt. Cooking reduces agaritine, a mildly toxic hydrazine compound found in raw button mushrooms, and improves digestibility of the chitinous cell walls. Aim for at least 200 g per week across multiple species, and rotate varieties for a broader spectrum of bioactives.

Common pitfalls

Pitfall 1: Believing the marketing claims

"Boosts immunity," "supports brain health," "promotes longevity" are all structure-function claims that require no FDA review and no evidence. They are marketing copy, not science. Memorial Sloan Kettering explicitly warns that many commercial mushroom products are promoted with claims that exceed the evidence. Look for the actual published trial data, not the label.

Pitfall 2: Treating supplements as drugs

The clinical effects of medicinal mushrooms are subtle and slow. People expect a caffeine-like acute response and conclude the supplement "does nothing" when they feel no immediate change. The cognitive effects of lion's mane, if real, require 8 to 16 weeks of consistent use to detect. The sleep and stress effects of reishi similarly accumulate over weeks. Set realistic expectations and track objectively.

Pitfall 3: Stacking five species at once

The wellness internet promotes "mushroom stacks" combining lion's mane, reishi, cordyceps, chaga, and turkey tail. This makes it impossible to know which species is doing what, and the immune-modulating effects of several species combined are unstudied. Start with one species, run it for 8 to 12 weeks, evaluate, then decide whether to add another.

Pitfall 4: Using mushrooms as a substitute for medical care

The most dangerous pitfall is using medicinal mushrooms to treat a serious condition, like cancer, in place of evidence-based therapy. Turkey tail and shiitake have adjuvant data in cancer, but always alongside conventional treatment, never in place of it. Discuss any mushroom use with your oncologist or treating physician.

The bottom line

Medicinal mushrooms contain real bioactives, primarily beta-glucans and terpenes, with mechanisms documented in animal and cellular studies. The human evidence is strongest for culinary mushrooms as part of a varied diet, modest for lion's mane and reishi in specific contexts, and limited for the rest. The supplement market is plagued by adulteration, mislabeling, and poor disclosure, which makes product quality the dominant variable. Use the Memorial Sloan Kettering About Herbs database and NCCIH as primary sources, demand third-party testing, and view any single mushroom as a small input to a broader lifestyle rather than a pharmacological intervention.